The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This post examines characteristics of adolescents ages 12 to 15 across in the United States to inform COVID-19 vaccination efforts once they become eligible to receive a vaccine.
This analysis uses CDC data to look at vaccination rates for adults 65 and older. The findings show that vaccination rates vary by county and that adults ages 65 and older are less likely to be fully vaccinated in counties in the South, in counties where a higher share of older adults live in poverty, and in counties that voted for Trump.
Most states require parental consent at this point, though the landscape may be shifting slightly as more jurisdictions seek to encourage vaccination of young people. Parents and parental consent laws will play a critical role in the COVID-19 vaccination effort to reach children in the U.S., particularly as authorization moves to even younger ages.
The latest KFF Health Tracking Poll explores the public's views on the U.S. role in distributing COVID vaccines to other countries, health care priorities for Congress, prescription drug regulations and price negotiations, and affordability changes in the COVID-19 relief bill.
This report explores the roughly a third of adults who have not received a COVID-19 vaccine and finds that, compared to vaccinated adults, they are younger, more likely to identify as Republican or Republican-leaning, with lower incomes and education levels, and more likely to be uninsured.
A new KFF issue brief lays out key factors for the successful rollout of COVID-19 vaccinations for younger children, ages 5 to 11. This week, the Food and Drug Administration’s (FDA) advisory committee will meet to vote on a request to authorize the Pfizer vaccine for younger children. A final FDA decision, and Centers for Disease Control and Prevention actions, will follow as soon as the first week in November. As the Biden administration plans…
In this Axios column, Drew Altman examines the data about what parents say they will do once their children ages 5-11 become eligible for a COVID-19 vaccine, and why it will take some time and a concerted outreach effort to match adult vaccination rates.
This data note reviews data currently available at the federal and state level on race/ethnicity of booster shot recipients of COVID-19 vaccines.
Among Those Who Have Not Been Vaccinated, 3 in 10 Are Unsure if They are Eligible Yet; Hispanic Adults and People with Low Incomes More Likely to Be Unsure The latest KFF COVID-19 Vaccine Monitor report finds enthusiasm for getting a COVID-19 vaccine continuing to grow, with roughly 6 in 10 adults (61%) now saying they have already gotten at least one dose (32%) or want to get vaccinated as soon as they can (30%).…
An analysis of Centers for Disease Control and Prevention (CDC) COVID-19 vaccination data from 72% of all counties in the U.S. shows that counties classified as having “low” COVID-19 community transmission (cases and positive tests) levels have an average vaccination rate greater than the rate in counties with “high” community transmission levels. Additionally, counties with the lowest COVID-19 deaths per 100,000 people have an average vaccination rate greater than the rates in counties with the…
© 2026 KFF
